These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 9567594)

  • 1. Measles, mumps, rubella vaccine induced subacute sclerosing panencephalitis.
    Belgamwar RB; Prasad S; Appaya P
    J Indian Med Assoc; 1997 Nov; 95(11):594. PubMed ID: 9567594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jul; 45(28):603-6. PubMed ID: 8676852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.
    Modlin JF; Jabbour JT; Witte JJ; Halsey NA
    Pediatrics; 1977 Apr; 59(4):505-12. PubMed ID: 850592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in the reactogenicity of measles-mumps-rubella vaccine.
    Shohat T; Green MS; Nakar O; Ballin A; Duvdevani P; Cohen A; Shohat M
    Isr Med Assoc J; 2000 Mar; 2(3):192-5. PubMed ID: 10774264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lidocaine-prilocaine patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response.
    Halperin SA; McGrath P; Smith B; Houston T
    J Pediatr; 2000 Jun; 136(6):789-94. PubMed ID: 10839878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles, measles vaccination, and Crohn's disease. Second immunisation has not affected incidence in England.
    Miller E; Waight P
    BMJ; 1998 Jun; 316(7146):1745. PubMed ID: 9614036
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.
    D'Souza RM; Campbell-Lloyd S; Isaacs D; Gold M; Burgess M; Turnbull F; O'Brien E
    Commun Dis Intell; 2000 Feb; 24(2):27-33. PubMed ID: 10758692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMR vaccination and autism 1998. Those giving MMR vaccine had no input into editorial.
    Kiln MR
    BMJ; 1998 Jun; 316(7147):1824. PubMed ID: 9652942
    [No Abstract]   [Full Text] [Related]  

  • 10. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral total deafness as a complication of the measles-mumps-rubella vaccination.
    Nabe-Nielsen J; Walter B
    Scand Audiol Suppl; 1988; 30():69-70. PubMed ID: 3227284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination.
    Vlacha V; Forman EN; Miron D; Peter G
    Pediatrics; 1996 May; 97(5):738-9. PubMed ID: 8628619
    [No Abstract]   [Full Text] [Related]  

  • 13. Measles, measles vaccination, and Crohn's disease. Age specific prevalences do not suggest association with in utero exposure.
    Lawrenson R; Farmer R
    BMJ; 1998 Jun; 316(7146):1746. PubMed ID: 9652933
    [No Abstract]   [Full Text] [Related]  

  • 14. Measles, measles vaccination, and Crohn's disease. Crohn's disease has not increased in Finland.
    Pebody RG; Paunio M; Ruutu P
    BMJ; 1998 Jun; 316(7146):1745-6. PubMed ID: 9652932
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella].
    Autret E; Jonville-Béra AP; Galy-Eyraud C; Hessel L
    Therapie; 1996; 51(6):677-80. PubMed ID: 9164004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMR vaccination, Crohn's disease and autism: a real or imagined "stomach ache/headache?".
    Passwell JH
    Isr Med Assoc J; 1999 Nov; 1(3):176-7. PubMed ID: 10731330
    [No Abstract]   [Full Text] [Related]  

  • 17. Autism, viral infection and measles-mumps-rubella vaccination.
    Wakefield AJ; Montgomery SM
    Isr Med Assoc J; 1999 Nov; 1(3):183-7. PubMed ID: 10731332
    [No Abstract]   [Full Text] [Related]  

  • 18. Measles, mumps, rubella vaccine: through a glass, darkly.
    Wakefield AJ; Montgomery SM
    Adverse Drug React Toxicol Rev; 2000 Dec; 19(4):265-83; discussion 284-92. PubMed ID: 11212459
    [No Abstract]   [Full Text] [Related]  

  • 19. MMR vaccination and autism 1998. Medical practitioners need to give more than reassurance.
    Selway
    BMJ; 1998 Jun; 316(7147):1824. PubMed ID: 9652941
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical safety issues of measles, mumps and rubella vaccines.
    Afzal MA; Minor PD; Schild GC
    Bull World Health Organ; 2000; 78(2):199-204. PubMed ID: 10743285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.